Literature DB >> 9436753

HIV Tat protein requirements for transactivation and repression of transcription are separable.

J A Brown1, T K Howcroft, D S Singer.   

Abstract

The HIV Tat protein, primarily characterized as a transcriptional activator of the viral long terminal repeat (LTR), is also a potent repressor of major histocompatibility complex (MHC) class I transcription. In the present study, we demonstrate that these two functional activities are distinct and mediated by discrete, but overlapping, structural domains of Tat. Tat repressor activity depends on C-terminal sequences, whereas transactivation depends on N-terminal sequences; both functions require core sequences. The repressor activity requires a domain encompassing the region encoded by the second exon of the Tat gene, beginning at amino acid 73, with a C-terminal limit between amino acids 80 and 83. Tat repressor function also depends on the presence of a lysine at position 41, located within the core of the protein. Tat repressor activity is independent of two N-terminal domains essential for transactivation: the acidic segment and the cysteine-rich region. Conversely, Tat transactivation is independent of the second exon-encoded region of Tat. As further support for this novel model of separable Tat functions, we show that in murine fibroblasts, Tat represses class I promoter activity, but does not transactivate the HIV LTR. We propose that distinct structural domains mediate the two functionally distinct activities associated with the Tat protein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9436753     DOI: 10.1097/00042560-199801010-00002

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  7 in total

1.  Molecular dynamics simulations on HIV-1 Tat.

Authors:  Sergio Pantano; Mudit Tyagi; Mauro Giacca; Paolo Carloni
Journal:  Eur Biophys J       Date:  2003-11-08       Impact factor: 1.733

2.  Novel Tat-encoding bicistronic human immunodeficiency virus type 1-based gene transfer vectors for high-level transgene expression.

Authors:  N Srinivasakumar; F Schuening
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 3.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

4.  Evaluation of Tat-encoding bicistronic human immunodeficiency virus type 1 gene transfer vectors in primary canine bone marrow mononuclear cells.

Authors:  Narasimhachar Srinivasakumar; Michail Zaboikin; Tatiana Zaboikina; Friedrich Schuening
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

5.  HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class I genes.

Authors:  J D Weissman; J A Brown; T K Howcroft; J Hwang; A Chawla; P A Roche; L Schiltz; Y Nakatani; D S Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

6.  Inflammatory papillomatous hyperplasia and epidermal necrosis in a transgenic rat for HIV-1.

Authors:  Filiberto Cedeno-Laurent; Joseph Bryant; Rita Fishelevich; Odell D Jones; April Deng; Maria L Eng; Anthony A Gaspari; J Roberto Trujillo
Journal:  J Dermatol Sci       Date:  2008-11-11       Impact factor: 4.563

Review 7.  Tat gets the "green" light on transcription initiation.

Authors:  John Brady; Fatah Kashanchi
Journal:  Retrovirology       Date:  2005-11-09       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.